Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

... reporting requirements arguing it would threaten attorney-client privilege: (Law360), US: Does Congress need a lesson on biotechnology or economics? - discussion of Washington Post article on Ismed's efforts to promote follow-on biologics approval pathway: ... W Henry Wall's cardiovascular stent patent invalid: (Law360), Boston Scientific - Medtronic sues Boston Scientific, Abbott alleging infringement of drug-eluting stent patent: (Law360), Boston Scientific - Patent infringement damages award to ...

... launches Generic Sourcing Program to reduce pharmacy spend: (GenericsWeb), US: Commonwealth Biotechnologies announces issuance of patent related to real time PCR detection of herpes virus: ... drug dealers' details in patent case Eli Lilly & Co Ltd v Neopharma Ltd & Anor: (IPKat), Zyprexa (Olanzapine) - Eli Lilly fails ... issues mixed ruling in patent infringement suit filed by University of California and Abbott against Dakocytomation: (Patent Docs), (IP Updates), Delphi - Bankrupt auto parts ...

... & IP), (BIO SmartBrief), (IP Law360), (GenericsWeb), Kaletra (Lopinavir/Ritonvair) - Developments on Kaletra/Abbott's registration withdrawal in Thailand: (Generic Pharmaceuticals & IP), Kytril (Granisetron) - FDA issues response on ... paper on private copying of films and photos: (LawFont.com), (IPwar's), (Michael Geist), Government publishes 'Biotechnology Business Indicators November 2007', including statistics about market capitalisation, clinical trial announcements and approvals and ...

... : Patent exception proposal to allow export of generic pharmaceuticals to developing countries: (IPKat), EU: ECJ to give guidance on Biotechnology Directive in Round Up case referred by District Court of The Hague: (IPEG) South Africa: Pharma investment in South Africa ... with Repligen and University of Michigan over Orencia: (IPBiz), (IP Law360), Tarka (Tandolapril/Verapamil) - Sanofi, Abbott sue Glenmark for patent infringement over plans to launch generic version of Tarka: (IP Law360), Topamax ( ...

... NOC proceedings as setting binding precedent in uncertain questions of patent law: Ranbaxy Laboratories Ltd v Pfizer Canada: (Gowlings), Livial (Tibolone) - Scotland: Court revokes Tibolone patent ... issuing NOC to generic company without requiring them to address two patents on the Register: Abbott Lab's v Canada (Minister of Health): (Gowlings), Propecia (Finasteride) - UK: ... ), Hindsight and commercial success: ITW AFC Pty Ltd v Loi and Tran Pty Ltd: (IPRoo) Do we need a bill of rights? - Van Thanh ...

... ?: (Against Monopoly), Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens), A skeptical look at the Automated Content Access Protocol: (Ars Technica), 5 practical ... infringement action against LensWorld for keyword advertising and mimicking their FAQs: (Trademark Blog) Abbott Laboratories - Abbott appeals a multiplicity of issues with varying success in its patent dispute with Innogenetics : (Patently-O), (Patent ...

... & IP) Switzerland: Discussion of Swiss Federal Ethics Committee on Non-Human Biotechnology report 'The dignity of living beings with regard to plants' and possible impact on patentability exceptions: ... passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott's first quarter lobbying tab hits $880,000: (Patent Docs), ... Validity of trade mark registration decision adjourns infringement proceedings: BDA Private Ltd v Paul P John: (International Law Office), Commerce Minister to make ...

... , pharma industries to target IP protection legislation, patent reform (Intellectual Property Watch) International Expert Group on Biotechnology, Innovation and Intellectual Property releases 'Toward a New Era of Intellectual Property: From Confrontation to Negotiation' report ... and Pfizer's 'Sutent' (Patent Circle) (Spicy IP) TriCor (Fenofibrate) -US: Court will not hear claims Abbott Laboratories and Fournier Industrie et Sante deceived the Patent Office but will hear claims the companies filed ...

... affordable healthcare campaign (SmartBrief) US: Discussion of NYT article 'Crop Scientists Say Biotechnology Seed Companies are Thwarting Research' (Patent Docs) (Patent Baristas) US FDA: ... suit over Perkin Elmer's marketing of Modified Sequential Screening protocol: Intema Ltd v NTD Laboratories, Inc et al (Patent Docs) US: District ... refuses to dismiss bulk of claims in patent, antitrust suit brought by Ethypharm against Abbott Lab's Tykerb (Lapatinib) - India: Cipla files post-grant opposition ...